Participants
Contact
The Spanish science news website Materia reports on the European project, Nabarsi. The initiative, in which IRB spin off Omnia Molecular plays a strategic role, aims to develop strategies to fight bacteria resistance.
Lluís Ribas de Pouplana, IRB researcher and founder of Omnia Molecular, gives details on the technology developed by the company that will help to identify therapeutic molecules to be developed as drugs.
Read the article here (PDF in Spanish)
Link to the article in Materia
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
